List of Excipients in API oxycodone hcl controlled-release
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing oxycodone hcl controlled-release
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Ranbaxy Pharmaceuticals Inc | OXYCODONE HCL CONTROLLED-RELEASE | oxycodone hcl controlled-release | 63304-400 | EUDRAGIT RS 30 | |
| Ranbaxy Pharmaceuticals Inc | OXYCODONE HCL CONTROLLED-RELEASE | oxycodone hcl controlled-release | 63304-400 | HYDROXYPROPYL CELLULOSE | |
| Ranbaxy Pharmaceuticals Inc | OXYCODONE HCL CONTROLLED-RELEASE | oxycodone hcl controlled-release | 63304-400 | HYPROMELLOSE | |
| Ranbaxy Pharmaceuticals Inc | OXYCODONE HCL CONTROLLED-RELEASE | oxycodone hcl controlled-release | 63304-400 | LACTOSE | |
| Ranbaxy Pharmaceuticals Inc | OXYCODONE HCL CONTROLLED-RELEASE | oxycodone hcl controlled-release | 63304-400 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for oxycodone hcl controlled-release
Excipient focus: EUDRAGIT RS 30
oxycodone hcl controlled-release drug variants containing EUDRAGIT RS 30
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | oxycodone hcl controlled-release | 63304-400 |
| >Company | >Ingredient | >NDC |
oxycodone hcl controlled-release drug variants not containing EUDRAGIT RS 30
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
oxycodone hcl controlled-release drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | oxycodone hcl controlled-release | 63304-400 |
| >Company | >Ingredient | >NDC |
oxycodone hcl controlled-release drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
oxycodone hcl controlled-release drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | oxycodone hcl controlled-release | 63304-400 |
| >Company | >Ingredient | >NDC |
oxycodone hcl controlled-release drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
oxycodone hcl controlled-release drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | oxycodone hcl controlled-release | 63304-400 |
| >Company | >Ingredient | >NDC |
oxycodone hcl controlled-release drug variants not containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
oxycodone hcl controlled-release drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | oxycodone hcl controlled-release | 63304-400 |
| >Company | >Ingredient | >NDC |
oxycodone hcl controlled-release drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
oxycodone hcl controlled-release drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | oxycodone hcl controlled-release | 63304-400 |
| >Company | >Ingredient | >NDC |
oxycodone hcl controlled-release drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
oxycodone hcl controlled-release drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | oxycodone hcl controlled-release | 63304-400 |
| >Company | >Ingredient | >NDC |
oxycodone hcl controlled-release drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
oxycodone hcl controlled-release drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | oxycodone hcl controlled-release | 63304-400 |
| >Company | >Ingredient | >NDC |
oxycodone hcl controlled-release drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBIC ACID
oxycodone hcl controlled-release drug variants containing SORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | oxycodone hcl controlled-release | 63304-400 |
| >Company | >Ingredient | >NDC |
oxycodone hcl controlled-release drug variants not containing SORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARYL ALCOHOL
oxycodone hcl controlled-release drug variants containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | oxycodone hcl controlled-release | 63304-400 |
| >Company | >Ingredient | >NDC |
oxycodone hcl controlled-release drug variants not containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
oxycodone hcl controlled-release drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | oxycodone hcl controlled-release | 63304-400 |
| >Company | >Ingredient | >NDC |
oxycodone hcl controlled-release drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
oxycodone hcl controlled-release drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | oxycodone hcl controlled-release | 63304-400 |
| >Company | >Ingredient | >NDC |
oxycodone hcl controlled-release drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
oxycodone hcl controlled-release drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | oxycodone hcl controlled-release | 63304-400 |
| >Company | >Ingredient | >NDC |
oxycodone hcl controlled-release drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
